Skip to main content
. 2023 Aug 21;29(1):e118–e130. doi: 10.1093/oncolo/oyad238

Table 3.

Microscopic features of available biopsies of patients experiencing immune-mediated diarrhea and colitis.

Variable N (%)
Number of cases 25 (100.0)
Crypt atrophy/loss
 Present 12 (48.0)
 Absent 13 (52.0)
Crypt distortion
 Present 15 (60.0)
 Absent 10 (40.0)
Mucin depletion
 Present 20 (80.0)
 Absent 5 (20.0)
Apoptotic bodies
 Present 19 (76.0)
 Absent 6 (24.0)
Lamina propria expansion
 Present 21 (84.0)
 Absent 4 (16.0)
Collagenous band
 Absent 16 (64.0)
 Focal 5 (20.0)
 Extensive 4 (16.0)
Intraepithelial lymphocytes
 Absent 1 (4.0)
 0-2/100 enterocytes 11 (44.0)
 3-20/100 enterocytes 13 (52.0)
 >20/100 enterocytes 0 (0.0)
Lymphomonocytic infiltrate
 Absent 0 (0.0)
 Mild 8 (32.0)
 Moderate 17 (68.0)
 Heavy 0 (0.0)
Granulocyte infiltrate
 Absent 13 (52.0)
 Mild 11 (44.0)
 Moderate 1 (4.0)
 Heavy 0 (0.0)
Cryptitis
 Absent 20 (80.0)
 Focally present 3 (12.0)
 Focally present 2 (8.0)
Crypt abscess
 Present 2 (8.0)
 Absent 23 (82.0)
Subepithelial macrophages
 Present 6 (24.0)
 Absent 19 (76.0)
Superficial erosion/ulceration
 Present 5 (20.0)
 Absent 20 (80.0)
Ischemic colitis like
 Present 6 (24.0)
 Absent 19 (76.0)
Paneth metaplasia
 Present 7 (28.0)
 Absent 18 (72.0)
Global score
 1 9 (36.0)
 2 9 (36.0)
 3 7 (28.0)